Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2026-01-01 @ 5:00 PM
Study NCT ID:
NCT04575935
Status:
RECRUITING
Last Update Posted:
2025-09-10
First Post:
2020-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Ovarian Carcinoma | View |
| None | Fallopian Tube Clear Cell Adenocarcinoma | View |
| None | Fallopian Tube Endometrioid Tumor | View |
| None | Fallopian Tube Serous Neoplasm | View |
| None | Fallopian Tube Transitional Cell Carcinoma | View |
| None | Ovarian Clear Cell Adenocarcinoma | View |
| None | Ovarian Endometrioid Adenocarcinoma | View |
| None | Ovarian Serous Adenocarcinoma | View |
| None | Ovarian Transitional Cell Carcinoma | View |
| None | Primary Peritoneal Clear Cell Adenocarcinoma | View |
| None | Primary Peritoneal Endometrioid Adenocarcinoma | View |
| None | Primary Peritoneal Serous Adenocarcinoma | View |
| None | Primary Peritoneal Transitional Cell Carcinoma | View |
| None | Stage IIIC Fallopian Tube Cancer AJCC v8 | View |
| None | Stage IIIC Ovarian Cancer AJCC v8 | View |
| None | Stage IIIC Primary Peritoneal Cancer AJCC v8 | View |
| None | Stage IV Fallopian Tube Cancer AJCC v8 | View |
| None | Stage IV Ovarian Cancer AJCC v8 | View |
| None | Stage IV Primary Peritoneal Cancer AJCC v8 | View |
| None | Stage IVA Fallopian Tube Cancer AJCC v8 | View |
| None | Stage IVA Ovarian Cancer AJCC v8 | View |
| None | Stage IVA Primary Peritoneal Cancer AJCC v8 | View |
| None | Stage IVB Fallopian Tube Cancer AJCC v8 | View |
| None | Stage IVB Ovarian Cancer AJCC v8 | View |
| None | Stage IVB Primary Peritoneal Cancer AJCC v8 | View |
Keywords: